Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Akero Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
AKRO
Nasdaq
8731
https://www.akerotx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Akero Therapeutics Inc
Akero Therapeutics Appoints Patrick Lamy as Senior Vice President, Commercial Strategy
- Jan 10th, 2023 1:00 pm
Akero Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
- Jan 4th, 2023 1:00 pm
Akero Therapeutics Outlines Expected 2023 Milestones For Lead NASH Program
- Dec 22nd, 2022 12:44 pm
Akero Therapeutics Completes Enrollment of Phase 2b SYMMETRY Study and Announces Expected 2023 Milestones
- Dec 21st, 2022 9:01 pm
Madrigal (MDGL) Soars as Resmetirom Meets Goal in NASH Study
- Dec 20th, 2022 4:15 pm
Efruxifermin Granted FDA Breakthrough Therapy Designation for NASH
- Dec 8th, 2022 12:00 pm
Akero Therapeutics, Inc.'s (NASDAQ:AKRO) large institutional owners must be happy as stock continues to impress, up 5.6% over the past week
- Nov 13th, 2022 12:46 pm
Akero Therapeutics to Present at Upcoming Healthcare Conferences in November
- Nov 10th, 2022 9:05 pm
Are Medical Stocks Lagging Akero Therapeutics (AKRO) This Year?
- Nov 7th, 2022 2:40 pm
Akero Therapeutics to Present Late-Breaking Oral and Poster presentations on EFX Today at AASLD’s The Liver Meeting® 2022
- Nov 7th, 2022 12:30 pm
Akero Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
- Nov 4th, 2022 11:00 am
10 Best Small-Cap Stocks To Buy Now
- Nov 3rd, 2022 10:53 pm
Novo Nordisk's (NVO) Q3 Earnings & Revenues Beat Estimates
- Nov 2nd, 2022 3:14 pm
Gilead (GILD) Inks Deal for Gene Platform in Blood Cancers
- Oct 21st, 2022 4:27 pm
AbbVie (ABBV) to Boost Immunology Pipeline With New Acquisition
- Oct 21st, 2022 4:06 pm
Are Medical Stocks Lagging AVEO Pharmaceuticals (AVEO) This Year?
- Oct 21st, 2022 1:40 pm
Why J.P. Morgan Believes These 3 Stocks Are Attractive in the Current Market
- Oct 12th, 2022 12:56 am
Akero Therapeutics to Present at the H.C. Wainwright 6th Annual NASH Investor Conference
- Oct 11th, 2022 8:01 pm
Is Akero Therapeutics (AKRO) Outperforming Other Medical Stocks This Year?
- Oct 5th, 2022 1:40 pm
Akero Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
- Sep 19th, 2022 8:01 pm
Scroll